Catalyst Pharmaceuticals Inc (CPRX) Q3 2025 Earnings Report Preview: What To Look For

This article first appeared on GuruFocus.

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) is set to release its Q3 2025 earnings on Nov 5, 2025. The consensus estimate for Q3 2025 revenue is $0.14 billion, and the earnings are expected to come in at $0.33 per share. The full year 2025's revenue is expected to be $0.56 billion and the earnings are expected to be $1.46 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 2 Warning Sign with CPRX.

Is CPRX fairly valued? Test your thesis with our free DCF calculator.

Over the past 90 days, revenue estimates for Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) have increased from $0.56 billion to $0.56 billion for the full year 2025. For 2026, revenue estimates have declined from $0.61 billion to $0.61 billion. Earnings estimates have remained stable at $1.46 per share for the full year 2025 and $1.69 per share for 2026.

In the previous quarter of 2025-06-30, Catalyst Pharmaceuticals Inc's (NASDAQ:CPRX) actual revenue was $0.15 billion, which beat analysts' revenue expectations of $0.14 billion by 4.24%. Catalyst Pharmaceuticals Inc's (NASDAQ:CPRX) actual earnings were $0.41 per share, which beat analysts' earnings expectations of $0.39 per share by 6.22%. After releasing the results, Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) was down by 1.94% in one day.

Based on the one-year price targets offered by 8 analysts, the average target price for Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) is $34.00 with a high estimate of $40.00 and a low estimate of $31.00. The average target implies an upside of 58.51% from the current price of $21.45.

Based on GuruFocus estimates, the estimated GF Value for Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) in one year is $26.40, suggesting an upside of 23.08% from the current price of $21.45.

Based on the consensus recommendation from 8 brokerage firms, Catalyst Pharmaceuticals Inc's (NASDAQ:CPRX) average brokerage recommendation is currently 1.4, indicating a \\"Buy\\" status. The rating scale ranges from 1 to 5, where 1 signifies strong buy, and 5 denotes sell.

Scroll to Top